122 related articles for article (PubMed ID: 4590871)
1. The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
Schildkraut JJ
Psychopharmacol Bull; 1974 Jan; 10(1):5-25. PubMed ID: 4590871
[No Abstract] [Full Text] [Related]
2. Biogenic amines and affective disorders.
Schildkraut JJ
Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
[No Abstract] [Full Text] [Related]
3. Understanding biochemical pathology of depressive illness. An overview.
Jain M; Jain KM
Psychiatr Neurol Neurochir; 1973; 76(4):285-95. PubMed ID: 4354410
[No Abstract] [Full Text] [Related]
4. [Effect of amitriptyline on the activity of enzymes participating in biogenic amine metabolism in patients with affective disorders].
Matsumoto H; Pietruszewska I; Marcjan K
Psychiatr Pol; 1983; 17(5-6):417-20. PubMed ID: 6669662
[No Abstract] [Full Text] [Related]
5. Genetic studies of CSF monoamine metabolites.
Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
[No Abstract] [Full Text] [Related]
6. Simulated behavior states: an approach to specificity in psychobiological research.
Post RM; Goodwin FK
Biol Psychiatry; 1973 Dec; 7(3):237-54. PubMed ID: 4357567
[No Abstract] [Full Text] [Related]
7. [Respective position of antidepressants in therapeutics (author's transl)].
Moussaoui D
Encephale; 1979; 5(5 Suppl):701-8. PubMed ID: 95010
[TBL] [Abstract][Full Text] [Related]
8. [Biologic markers and prediction of response to treatment in depression].
Uytdenhoef P; Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
[No Abstract] [Full Text] [Related]
9. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
[No Abstract] [Full Text] [Related]
10. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
[No Abstract] [Full Text] [Related]
11. [Therapeutic implications of the biochemical features about depressive illness (author's transl)].
Lôo H
Encephale; 1981; 7(4 Suppl):429-40. PubMed ID: 6172268
[TBL] [Abstract][Full Text] [Related]
12. [Biochemistry of depression and antidepressants].
Strolin Benedetti M
Encephale; 1982; 8(5):545-85. PubMed ID: 6189704
[TBL] [Abstract][Full Text] [Related]
13. Biodevelopmental aspects of conduct disorder in boys.
Gabel S; Stadler J; Bjorn J; Shindledecker R; Bowden CL
Child Psychiatry Hum Dev; 1993; 24(2):125-41. PubMed ID: 7507018
[TBL] [Abstract][Full Text] [Related]
14. Psychomotor activity, sleep, and biogenic amine metabolites in depression.
Weiss BL; Kupfer DJ; Foster FG; Delgado J
Biol Psychiatry; 1974 Aug; 9(1):45-54. PubMed ID: 4376024
[No Abstract] [Full Text] [Related]
15. [Modifications of cerebral amine metabolism in psychiatric illness].
Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
[TBL] [Abstract][Full Text] [Related]
16. Monoamine metabolism and depression in Parkinson patients.
Puite JK; Schut T; van Praag HM; Lakke JP
Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
[No Abstract] [Full Text] [Related]
17. [Metabolism and pathology of catecholamines].
Traba ML
Rev Clin Esp; 1981 Jul 15-31; 162(1-2):5-13. PubMed ID: 6117933
[No Abstract] [Full Text] [Related]
18. [Biological aspects of suicide].
Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1983; 83(1):7-12. PubMed ID: 6193681
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
Faull KF; Guilleminault C; Berger PA; Barchas JD
Ann Neurol; 1983 Mar; 13(3):258-63. PubMed ID: 6189447
[TBL] [Abstract][Full Text] [Related]
20. Toward a biochemical classification of depression.
van Praag HM
Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
